The Biocard™ Celiac Test is a rapid, simple and reliable test for the detection of IgA antibodies against tissue transglutaminase (tTG) . The semiquantitative determination of IgA-tTG antibodies is a useful diagnostic test in suspected celiac disease, a screening test in the group at risk of developing celiac disease, and a useful test in assessing compliance with a gluten-free diet. The starting material for the test is blood taken from the fingertip .

Celiac disease, also known as celiac disease or gluten-sensitive enteropathy, is a lifelong autoimmune disease with a genetic basis. There is an abnormal reaction of the immune system as a result of eating gluten - a storage protein contained in grains, including wheat, rye and barley).

As a result of the action of gluten, an abnormal immune reaction is directed against the body's own tissues, especially in the small intestine, which leads to inflammation and damage to the mucous membrane of the small intestine and then to the disappearance of the intestine. villi, which increase its surface area and are responsible for the absorption of nutritional ingredients. As a result, food absorption is impaired, leading to various clinical symptoms, including diarrhea, flatulence, weight loss, and even malnutrition. The only treatment for celiac disease is a strict, lifelong gluten-free diet.

When following a gluten-free diet, the level of IgA autoantibodies decreases, which can make them undetectable for up to 6 months after dietary changes are made. The Celiac Biocard™ test is therefore a valuable diagnostic tool for monitoring the effects of introducing a gluten-free diet*.

Biocard™ Celiac The test for celiac disease can be performed both at home and in the doctor's office by medical personnel. The kit contains all the elements necessary to collect the sample and perform the test, and the result is obtained in 5 minutes after the test.